ETIDIOH - NEW

  Highlights •  A Nipah virus real-time RT-PCR was developed for this study and display dynamic amplification, with sensitive (limit of detection 3.7-4.2 copies/µL) and specific detection. •  The assay was adapted for use on a portable, battery-powered real-time thermocycler . •  When paired with instrument-free RNA extraction , Nipah virus RNA was rapidly detected from contrived whole blood and nasopharyngeal swabs without electricity. •  The combined of Extract & Store and the Palm PCR S1e device offers a viable solution for field-based molecular detection of Nipah virus. Abstract Background Nipah virus (NiV) is a highly pathogenic, zoonotic paramyxovirus with significant public health implications due to high associated mortality and potential for human-to-human transmission. Current diagnostic testing options for NiV are limited and require extensive laboratory infrastructure. Objective Develop a field-deployable testing workflow for timely NiV detection...

  {Summary} Risk Statement   -- This Rapid Risk Assessment (RRA) evaluates the global public health risk posed by Nipah virus (NiV), considering the distinct epidemiological profiles of  - i) enzootic countries , where recurrent zoonotic spillover and limited human‑to‑human transmission continue to occur, and  - ii) non‑enzootic regions , where the risk remains primarily associated with infected travellers or importation of infected livestock.  -- The assessment considers the ecological and seasonal drivers of spillover , the constrained efficiency of human‑to‑human transmission , and the capacity of health and community systems to detect, confirm, and rapidly contain outbreaks.  -- Given that NiV has not demonstrated sustained transmission beyond outbreak settings and no human cases have ever been reported outside Asia , the global risk is largely determined by localized outbreaks in endemic areas and the very low likelihood of onward transmission fol...

  Abstract Nipah virus is a highly pathogenic virus in the family Paramyxoviridae that utilizes two distinct surface glycoproteins to infect cells . The receptor-binding protein (RBP) binds host receptors whereas the fusion protein (F) merges viral and host membranes . Here, we use nonreplicative pseudoviruses to safely measure the effects of all F single amino acid residue mutations on its cell entry function and neutralization by monoclonal antibodies . We compare mutational tolerance in F with previous experimental measurements for RBP and show that F is much more functionally constrained than the RBP . We also identify mutationally intolerant sites on the F trimer surface and core that are critical for proper function, and describe mutations that are candidates for stabilizing F in the prefusion conformation for vaccine design . We quantify how F mutations affect neutralization by six monoclonal antibodies, and show that the magnitude of mutational effects on neutralization var...

  6 February 2026 Situation at a glance On 3 February 2026, the International Health Regulations National Focal Point (IHR NFP) for Bangladesh notified WHO of one confirmed case of Nipah virus (NiV) infection in Rajshahi Division .  The patient developed fever and neurological symptoms on 21 January.  Nipah virus infection was laboratory-confirmed on 29 January.  The patient reported no travel history but had a history of consuming raw date palm sap .  All 35 contact-persons are being monitored and have tested negative for NiV and no further cases have been detected to date.  Bangladesh regularly has small NiV outbreaks , with cases reported at different times of the year, though outbreaks tend to occur between December and April corresponding with the harvesting and consumption of date palm sap.  The Ministry of Health and Family Welfare in Bangladesh has implemented several public health measures.  WHO assesses the overall public health risk pos...

  Situation at a glance On 26 January 2026, the National IHR Focal Point for India notified WHO of two laboratory‑confirmed cases of Nipah virus (NiV) infection in West Bengal State .  Both are healthcare workers at the same private hospital in Barasat (North 24 Parganas district).  NiV infection was confirmed at the National Institute of Virology in Pune on 13 January.  One case remains on mechanical ventilation as of 21 January, the other case experienced severe neurological illness but has since improved.  Authorities have identified and tested over 190 contacts , who all tested negative for NiV with support from a mobile BSL‑3 laboratory deployed by the National Institute of Virology, Pune.  No further cases have been detected to date.  This event represents the third NiV infection outbreak reported in West Bengal (previous outbreaks reported in Siliguri in 2001 and Nadia in 2007).  Enhanced surveillance and infection prevention and control (I...

  DH follows up on Nipah virus infection cluster in India In light of reports indicating a cluster of a Nipah virus infection in a certain region of India, the Centre for Health Protection (CHP) of the Department of Health (DH) said today (January 26) that it has proactively sought further information from the World Health Organization (WHO) and Indian health authorities .  The CHP is also conducting health screenings on inbound travellers from the affected area who exhibit suspected symptoms, with an aim of promptly referring suspected cases to hospitals for investigation.  Currently, there are no imported or local cases of Nipah virus infection in Hong Kong. Preliminary information indicated that a hospital in Kolkata, West Bengal, India, has recorded five confirmed cases of Nipah virus infection since mid-January of this year.  The cluster was mainly due to nosocomial transmission and primarily involved healthcare workers , with no reported deaths or cross-border ...

  Abstract Diseases caused by henipaviruses, exemplified by Hendra virus and Nipah virus, pose a serious risk to public health because of their epidemic potential and high case-fatality rates and the paucity of medical countermeasures to mitigate them. In December 2024, a group of 150 scientists from 16 countries convened in Geelong, Victoria, Australia, to mark the 30th anniversary of the discovery of Hendra virus . The Hendra@30 conference built upon its predecessor conference held in 2019 in Singapore, Nipah@20, by expanding its program across broader disciplines and integrating sessions on human sociology and disease ecology into the main scientific discussions. We describe key highlights from Hendra@30 and reflect on 4 key elements that have advanced henipavirus research and medical countermeasures research and development. We propose that integrating bat ecology into henipavirus research blueprints will enable development of ecologic countermeasures that prevent spillover and...

  Abstract Nipah virus (NiV) is a zoonotic pathogen that causes severe encephalitis and respiratory disease in humans and multiple mammalian species. However, no licensed vaccines or therapeutics are currently available against NiV infection. In this study, we developed three mRNA vaccine candidates using a lipid nanoparticle (LNP) delivery platform : mRNA-F-LNP, comprising mRNA encoding the fusion protein (F); mRNA-G-LNP, containing mRNA encoding the attachment glycoprotein (G); and mRNA-GF-LNP, in which mRNAs encoding both F and G proteins were co-encapsulated at a 1:1 molar ratio. All three mRNA-LNPs induced robust and sustained immune responses in both mice and Syrian hamsters . Sera from immunized Syrian hamster showed high levels of cross-neutralizing antibodies against both NiV-Malaysia (NiV-M) and NiV-Bangladesh (NiV-B) strains. Notably, all three mRNA-LNPs conferred complete protection against a lethal challenge with NiV-M in Syrian hamsters. These findings demonstrate tha...

  Summary Background First discovered in 1999 in Malaysia, Nipah virus (NiV) causes yearly outbreaks throughout south and southeast Asia with associated mortality rates of 40–75%. Due to the structural and sequence similarities between the NiV and Hendra virus (HeV) attachment G glycoproteins , and the extensive extant evidence of the ability of a recombinant soluble glycoprotein G (HeV-sG) to provide heterologous cross-protective immunity when used as vaccine (HeV-sG-V), this study aimed to evaluate HeV-sG-V for safety, tolerability, and immunogenicity against NiV. Methods We conducted a phase 1, single-centre, randomised, observer-blind, placebo-controlled study . Eligible participants were aged 18–49 years, healthy, and not pregnant ; participants were ineligible if they were immunocompromised, had received blood products within 6 months of enrolment, had potential exposure to NiV or HeV, or had known allergies to components of the vaccine. Participants were randomly assigned in...

  Summary Background First discovered in 1999 in Malaysia, Nipah virus (NiV) causes yearly outbreaks throughout south and southeast Asia with associated mortality rates of 40–75 %. Due to the structural and sequence similarities between the NiV and Hendra virus (HeV) attachment G glycoproteins , and the extensive extant evidence of the ability of a recombinant soluble glycoprotein G (HeV-sG) to provide heterologous cross-protective immunity when used as vaccine (HeV-sG-V), this study aimed to evaluate HeV-sG-V for safety, tolerability, and immunogenicity against NiV. Methods We conducted a phase 1, single-centre, randomised, observer-blind, placebo-controlled study . Eligible participants were aged 18–49 years, healthy, and not pregnant; participants were ineligible if they were immunocompromised, had received blood products within 6 months of enrolment, had potential exposure to NiV or HeV, or had known allergies to components of the vaccine. Participants were randomly assigned in...

  Situation at a glance Between 1 January and 29 August 2025, the International Health Regulations National Focal Point (IHR NFP) for Bangladesh notified WHO of four confirmed fatal Nipah virus (NiV) infection cases , temporally unrelated , reported from four different districts across three separated geographical divisions (Barisal, Dhaka, and Rajshahi) in Bangladesh.  NiV infection is a zoonotic disease transmitted to humans through infected animals (such as bats or pigs ), or food contaminated with saliva, urine , and excreta of infected animals .  It can also be transmitted directly from person to person through close contact with an infected person.  Fruit bats or flying foxes (Pteropus species) are the natural hosts for the virus.  Human NiV infection is an epidemic-prone disease that can cause severe disease in humans and animals, with a high mortality rate , and outbreaks primarily occurring in South and South-East Asia .  Since the first recognized...